Combinatorial selection of oligonucleotide aptamers
View Patent ↗A random combinatorial selection method is disclosed for the construction of oligonucleotide aptamers in which nuclease resistance is conferred by the inclusion of modified nucleotides. The modified nucleotides are incorporated during PCR amplification to form achiral modified oligonucleotides. Thio-substituted aptamers are provided that bind tightly to the nuclear factor for human IL6 (NF-IL6).
1. A NF-IL6 protein binding aptamer comprising a mix of unmodified and thiophosphate-modified nucleotides that form a partially thiophosphate-modified oligonucleotide identified by SEQ ID NO: 7, wherein at least one but no more than four of any one single nucleotide base is thiophosphate-modified, wherein the aptamer binds NF-IL6.
2. The aptamer of claim 1 , wherein the modified nucleotide base comprises a phosphorothioate.
3. The aptamer of claim 1 , wherein the modified nucleotide base comprises a phosphorodithioate.
4. The aptamer of claim 1 , wherein the modified nucleotide base is selected from the group consisting of dATP(αS), dTTP(αS), dCTP(αS) and dGTP(αS).
5. The aptamer of claim 1 , wherein no more than three adjacent phosphate sites are replaced with phosphorothioate groups.
6. The aptamer of claim 1 , wherein at least a portion of non-adjacent phosphate sites are replaced with phosphorothioate groups.
7. The aptamer of claim 1 , wherein no more than three adjacent phosphate sites are replaced with phosphorodithioate groups.
8. The aptamer of claim 1 , wherein at least a portion of non-adjacent phosphate sites are replaced with phosphorodithioate groups.